NDC 67877-458

Capecitabine

Capecitabine

Capecitabine is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Ascend Laboratories, Llc. The primary component is Capecitabine.

Product ID67877-458_14ed06e7-fe02-4590-9530-978ded847638
NDC67877-458
Product TypeHuman Prescription Drug
Proprietary NameCapecitabine
Generic NameCapecitabine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2017-11-25
Marketing CategoryANDA / ANDA
Application NumberANDA207652
Labeler NameAscend Laboratories, LLC
Substance NameCAPECITABINE
Active Ingredient Strength150 mg/1
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 67877-458-12

120 TABLET, FILM COATED in 1 BOTTLE (67877-458-12)
Marketing Start Date2017-11-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 67877-458-30 [67877045830]

Capecitabine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA207652
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-11-25

NDC 67877-458-12 [67877045812]

Capecitabine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA207652
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-11-25

NDC 67877-458-60 [67877045860]

Capecitabine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA207652
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-11-25

Drug Details

Active Ingredients

IngredientStrength
CAPECITABINE150 mg/1

OpenFDA Data

SPL SET ID:06a88b03-6c06-4dae-b3bc-1e8dd81c9067
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 200328
  • 200327
  • UPC Code
  • 0367877459301
  • 0367877458304
  • Pharmacological Class

    • Nucleic Acid Synthesis Inhibitors [MoA]
    • Nucleoside Metabolic Inhibitor [EPC]

    NDC Crossover Matching brand name "Capecitabine" or generic name "Capecitabine"

    NDCBrand NameGeneric Name
    0054-0271CapecitabineCapecitabine
    0054-0272CapecitabineCapecitabine
    0093-7473CapecitabineCapecitabine
    0093-7474CapecitabineCapecitabine
    0378-2511Capecitabinecapecitabine
    0378-2512Capecitabinecapecitabine
    16714-467CAPECITABINECAPECITABINE
    67877-458CapecitabineCapecitabine
    67877-459CapecitabineCapecitabine
    69097-949CapecitabineCapecitabine
    69097-948CapecitabineCapecitabine
    69539-019CapecitabineCapecitabine
    69539-020CapecitabineCapecitabine
    72205-006CapecitabineCapecitabine
    72205-007CapecitabineCapecitabine
    16714-468CAPECITABINECAPECITABINE
    16729-072CAPECITABINECAPECITABINE
    16729-073CAPECITABINECAPECITABINE
    42291-167CapecitabineCapecitabine
    50268-154CapecitabineCapecitabine
    51079-510CapecitabineCapecitabine
    51407-095CapecitabineCapecitabine
    51407-096CapecitabineCapecitabine
    59651-204CapecitabineCapecitabine
    59651-205CapecitabineCapecitabine
    60687-149CapecitabineCapecitabine
    63759-3000CapecitabineCapecitabine
    63759-3001CapecitabineCapecitabine
    64980-277CapecitabineCapecitabine
    64980-276CapecitabineCapecitabine
    65162-844CapecitabineCapecitabine
    65162-843CapecitabineCapecitabine
    0004-1100Xelodacapecitabine
    0004-1101Xelodacapecitabine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.